img

Global Daptomycin Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Daptomycin Market Insights, Forecast to 2034

Daptomycin is a lipopeptide antibiotic used in the treatment of systemic and life-threatening infections caused by Gram-positive organisms.
Global Daptomycin market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Daptomycin industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
Globally, Daptomycin key manufacturers include Merck & Co., Pfizer, Teva, Mylan, Fresenius Kabi, Sagent Pharmaceuticals, Xellia, Hisun and HENGRUI PHARMA, etc. Merck & Co., Pfizer, Teva are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Daptomycin were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Daptomycin market and estimated to attract more attentions from industry insiders and investors.
Daptomycin can be divided into 350 mg Lyophilized Powder and 500 mg Lyophilized Powder, etc. 350 mg Lyophilized Powder is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Daptomycin is widely used in various fields, such as Adult and Pediatric Patients (1 to 17 years of age), etc. Adult provides greatest supports to the Daptomycin industry development. In 2022, global % sales of Daptomycin went into Adult filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Daptomycin market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Daptomycin market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Merck & Co.
Pfizer
Teva
Mylan
Fresenius Kabi
Sagent Pharmaceuticals
Xellia
Hisun
HENGRUI PHARMA
Huadong Medicine
Segment by Type
350 mg Lyophilized Powder
500 mg Lyophilized Powder

Segment by Application


Adult
Pediatric Patients (1 to 17 years of age)

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Daptomycin plant distribution, commercial date of Daptomycin, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Daptomycin introduction, etc. Daptomycin Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Daptomycin
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Daptomycin Product Introduction
1.2 Market by Type
1.2.1 Global Daptomycin Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 350 mg Lyophilized Powder
1.2.3 500 mg Lyophilized Powder
1.3 Market by Application
1.3.1 Global Daptomycin Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Adult
1.3.3 Pediatric Patients (1 to 17 years of age)
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Daptomycin Sales Estimates and Forecasts 2018-2029
2.2 Global Daptomycin Revenue by Region
2.2.1 Global Daptomycin Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Daptomycin Revenue by Region (2018-2024)
2.2.3 Global Daptomycin Revenue by Region (2024-2029)
2.2.4 Global Daptomycin Revenue Market Share by Region (2018-2029)
2.3 Global Daptomycin Sales Estimates and Forecasts 2018-2029
2.4 Global Daptomycin Sales by Region
2.4.1 Global Daptomycin Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Daptomycin Sales by Region (2018-2024)
2.4.3 Global Daptomycin Sales by Region (2024-2029)
2.4.4 Global Daptomycin Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Daptomycin Sales by Manufacturers
3.1.1 Global Daptomycin Sales by Manufacturers (2018-2024)
3.1.2 Global Daptomycin Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Daptomycin in 2022
3.2 Global Daptomycin Revenue by Manufacturers
3.2.1 Global Daptomycin Revenue by Manufacturers (2018-2024)
3.2.2 Global Daptomycin Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Daptomycin Revenue in 2022
3.3 Global Key Players of Daptomycin, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Daptomycin Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Daptomycin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Daptomycin, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Daptomycin, Product Offered and Application
3.8 Global Key Manufacturers of Daptomycin, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Daptomycin Sales by Type
4.1.1 Global Daptomycin Historical Sales by Type (2018-2024)
4.1.2 Global Daptomycin Forecasted Sales by Type (2024-2029)
4.1.3 Global Daptomycin Sales Market Share by Type (2018-2029)
4.2 Global Daptomycin Revenue by Type
4.2.1 Global Daptomycin Historical Revenue by Type (2018-2024)
4.2.2 Global Daptomycin Forecasted Revenue by Type (2024-2029)
4.2.3 Global Daptomycin Revenue Market Share by Type (2018-2029)
4.3 Global Daptomycin Price by Type
4.3.1 Global Daptomycin Price by Type (2018-2024)
4.3.2 Global Daptomycin Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Daptomycin Sales by Application
5.1.1 Global Daptomycin Historical Sales by Application (2018-2024)
5.1.2 Global Daptomycin Forecasted Sales by Application (2024-2029)
5.1.3 Global Daptomycin Sales Market Share by Application (2018-2029)
5.2 Global Daptomycin Revenue by Application
5.2.1 Global Daptomycin Historical Revenue by Application (2018-2024)
5.2.2 Global Daptomycin Forecasted Revenue by Application (2024-2029)
5.2.3 Global Daptomycin Revenue Market Share by Application (2018-2029)
5.3 Global Daptomycin Price by Application
5.3.1 Global Daptomycin Price by Application (2018-2024)
5.3.2 Global Daptomycin Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Daptomycin Market Size by Type
6.1.1 US & Canada Daptomycin Sales by Type (2018-2029)
6.1.2 US & Canada Daptomycin Revenue by Type (2018-2029)
6.2 US & Canada Daptomycin Market Size by Application
6.2.1 US & Canada Daptomycin Sales by Application (2018-2029)
6.2.2 US & Canada Daptomycin Revenue by Application (2018-2029)
6.3 US & Canada Daptomycin Market Size by Country
6.3.1 US & Canada Daptomycin Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Daptomycin Sales by Country (2018-2029)
6.3.3 US & Canada Daptomycin Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Daptomycin Market Size by Type
7.1.1 Europe Daptomycin Sales by Type (2018-2029)
7.1.2 Europe Daptomycin Revenue by Type (2018-2029)
7.2 Europe Daptomycin Market Size by Application
7.2.1 Europe Daptomycin Sales by Application (2018-2029)
7.2.2 Europe Daptomycin Revenue by Application (2018-2029)
7.3 Europe Daptomycin Market Size by Country
7.3.1 Europe Daptomycin Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Daptomycin Sales by Country (2018-2029)
7.3.3 Europe Daptomycin Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Daptomycin Market Size
8.1.1 China Daptomycin Sales (2018-2029)
8.1.2 China Daptomycin Revenue (2018-2029)
8.2 China Daptomycin Market Size by Application
8.2.1 China Daptomycin Sales by Application (2018-2029)
8.2.2 China Daptomycin Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Daptomycin Market Size by Type
9.1.1 Asia Daptomycin Sales by Type (2018-2029)
9.1.2 Asia Daptomycin Revenue by Type (2018-2029)
9.2 Asia Daptomycin Market Size by Application
9.2.1 Asia Daptomycin Sales by Application (2018-2029)
9.2.2 Asia Daptomycin Revenue by Application (2018-2029)
9.3 Asia Daptomycin Sales by Region
9.3.1 Asia Daptomycin Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Daptomycin Revenue by Region (2018-2029)
9.3.3 Asia Daptomycin Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Daptomycin Market Size by Type
10.1.1 Middle East, Africa and Latin America Daptomycin Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Daptomycin Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Daptomycin Market Size by Application
10.2.1 Middle East, Africa and Latin America Daptomycin Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Daptomycin Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Daptomycin Sales by Country
10.3.1 Middle East, Africa and Latin America Daptomycin Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Daptomycin Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Daptomycin Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Merck & Co.
11.1.1 Merck & Co. Company Information
11.1.2 Merck & Co. Overview
11.1.3 Merck & Co. Daptomycin Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Merck & Co. Daptomycin Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merck & Co. Recent Developments
11.2 Pfizer
11.2.1 Pfizer Company Information
11.2.2 Pfizer Overview
11.2.3 Pfizer Daptomycin Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Pfizer Daptomycin Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Pfizer Recent Developments
11.3 Teva
11.3.1 Teva Company Information
11.3.2 Teva Overview
11.3.3 Teva Daptomycin Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Teva Daptomycin Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Teva Recent Developments
11.4 Mylan
11.4.1 Mylan Company Information
11.4.2 Mylan Overview
11.4.3 Mylan Daptomycin Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Mylan Daptomycin Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Mylan Recent Developments
11.5 Fresenius Kabi
11.5.1 Fresenius Kabi Company Information
11.5.2 Fresenius Kabi Overview
11.5.3 Fresenius Kabi Daptomycin Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Fresenius Kabi Daptomycin Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Fresenius Kabi Recent Developments
11.6 Sagent Pharmaceuticals
11.6.1 Sagent Pharmaceuticals Company Information
11.6.2 Sagent Pharmaceuticals Overview
11.6.3 Sagent Pharmaceuticals Daptomycin Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Sagent Pharmaceuticals Daptomycin Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Sagent Pharmaceuticals Recent Developments
11.7 Xellia
11.7.1 Xellia Company Information
11.7.2 Xellia Overview
11.7.3 Xellia Daptomycin Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Xellia Daptomycin Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Xellia Recent Developments
11.8 Hisun
11.8.1 Hisun Company Information
11.8.2 Hisun Overview
11.8.3 Hisun Daptomycin Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Hisun Daptomycin Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Hisun Recent Developments
11.9 HENGRUI PHARMA
11.9.1 HENGRUI PHARMA Company Information
11.9.2 HENGRUI PHARMA Overview
11.9.3 HENGRUI PHARMA Daptomycin Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 HENGRUI PHARMA Daptomycin Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 HENGRUI PHARMA Recent Developments
11.10 Huadong Medicine
11.10.1 Huadong Medicine Company Information
11.10.2 Huadong Medicine Overview
11.10.3 Huadong Medicine Daptomycin Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Huadong Medicine Daptomycin Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Huadong Medicine Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Daptomycin Industry Chain Analysis
12.2 Daptomycin Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Daptomycin Production Mode & Process
12.4 Daptomycin Sales and Marketing
12.4.1 Daptomycin Sales Channels
12.4.2 Daptomycin Distributors
12.5 Daptomycin Customers
13 Market Dynamics
13.1 Daptomycin Industry Trends
13.2 Daptomycin Market Drivers
13.3 Daptomycin Market Challenges
13.4 Daptomycin Market Restraints
14 Key Findings in The Global Daptomycin Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Daptomycin Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of 350 mg Lyophilized Powder
Table 3. Major Manufacturers of 500 mg Lyophilized Powder
Table 4. Global Daptomycin Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Daptomycin Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Daptomycin Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Daptomycin Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Daptomycin Revenue Market Share by Region (2018-2024)
Table 9. Global Daptomycin Revenue Market Share by Region (2024-2029)
Table 10. Global Daptomycin Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Daptomycin Sales by Region (2018-2024) & (K Units)
Table 12. Global Daptomycin Sales by Region (2024-2029) & (K Units)
Table 13. Global Daptomycin Sales Market Share by Region (2018-2024)
Table 14. Global Daptomycin Sales Market Share by Region (2024-2029)
Table 15. Global Daptomycin Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Daptomycin Sales Share by Manufacturers (2018-2024)
Table 17. Global Daptomycin Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Daptomycin Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Daptomycin, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Daptomycin Price by Manufacturers 2018-2024 (USD/Unit)
Table 21. Global Daptomycin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Daptomycin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Daptomycin as of 2022)
Table 23. Global Key Manufacturers of Daptomycin, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Daptomycin, Product Offered and Application
Table 25. Global Key Manufacturers of Daptomycin, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Daptomycin Sales by Type (2018-2024) & (K Units)
Table 28. Global Daptomycin Sales by Type (2024-2029) & (K Units)
Table 29. Global Daptomycin Sales Share by Type (2018-2024)
Table 30. Global Daptomycin Sales Share by Type (2024-2029)
Table 31. Global Daptomycin Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Daptomycin Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Daptomycin Revenue Share by Type (2018-2024)
Table 34. Global Daptomycin Revenue Share by Type (2024-2029)
Table 35. Daptomycin Price by Type (2018-2024) & (USD/Unit)
Table 36. Global Daptomycin Price Forecast by Type (2024-2029) & (USD/Unit)
Table 37. Global Daptomycin Sales by Application (2018-2024) & (K Units)
Table 38. Global Daptomycin Sales by Application (2024-2029) & (K Units)
Table 39. Global Daptomycin Sales Share by Application (2018-2024)
Table 40. Global Daptomycin Sales Share by Application (2024-2029)
Table 41. Global Daptomycin Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Daptomycin Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Daptomycin Revenue Share by Application (2018-2024)
Table 44. Global Daptomycin Revenue Share by Application (2024-2029)
Table 45. Daptomycin Price by Application (2018-2024) & (USD/Unit)
Table 46. Global Daptomycin Price Forecast by Application (2024-2029) & (USD/Unit)
Table 47. US & Canada Daptomycin Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Daptomycin Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Daptomycin Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Daptomycin Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Daptomycin Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Daptomycin Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Daptomycin Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Daptomycin Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Daptomycin Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Daptomycin Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Daptomycin Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Daptomycin Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Daptomycin Sales by Country (2024-2029) & (K Units)
Table 60. Europe Daptomycin Sales by Type (2018-2024) & (K Units)
Table 61. Europe Daptomycin Sales by Type (2024-2029) & (K Units)
Table 62. Europe Daptomycin Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Daptomycin Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Daptomycin Sales by Application (2018-2024) & (K Units)
Table 65. Europe Daptomycin Sales by Application (2024-2029) & (K Units)
Table 66. Europe Daptomycin Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Daptomycin Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Daptomycin Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Daptomycin Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Daptomycin Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Daptomycin Sales by Country (2018-2024) & (K Units)
Table 72. Europe Daptomycin Sales by Country (2024-2029) & (K Units)
Table 73. China Daptomycin Sales by Type (2018-2024) & (K Units)
Table 74. China Daptomycin Sales by Type (2024-2029) & (K Units)
Table 75. China Daptomycin Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Daptomycin Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Daptomycin Sales by Application (2018-2024) & (K Units)
Table 78. China Daptomycin Sales by Application (2024-2029) & (K Units)
Table 79. China Daptomycin Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Daptomycin Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Daptomycin Sales by Type (2018-2024) & (K Units)
Table 82. Asia Daptomycin Sales by Type (2024-2029) & (K Units)
Table 83. Asia Daptomycin Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Daptomycin Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Daptomycin Sales by Application (2018-2024) & (K Units)
Table 86. Asia Daptomycin Sales by Application (2024-2029) & (K Units)
Table 87. Asia Daptomycin Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Daptomycin Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Daptomycin Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Daptomycin Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Daptomycin Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Daptomycin Sales by Region (2018-2024) & (K Units)
Table 93. Asia Daptomycin Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Daptomycin Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Daptomycin Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Daptomycin Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Daptomycin Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Daptomycin Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Daptomycin Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Daptomycin Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Daptomycin Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Daptomycin Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Daptomycin Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Daptomycin Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Daptomycin Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Daptomycin Sales by Country (2024-2029) & (K Units)
Table 107. Merck & Co. Company Information
Table 108. Merck & Co. Description and Major Businesses
Table 109. Merck & Co. Daptomycin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 110. Merck & Co. Daptomycin Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Merck & Co. Recent Developments
Table 112. Pfizer Company Information
Table 113. Pfizer Description and Major Businesses
Table 114. Pfizer Daptomycin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 115. Pfizer Daptomycin Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Pfizer Recent Developments
Table 117. Teva Company Information
Table 118. Teva Description and Major Businesses
Table 119. Teva Daptomycin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 120. Teva Daptomycin Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Teva Recent Developments
Table 122. Mylan Company Information
Table 123. Mylan Description and Major Businesses
Table 124. Mylan Daptomycin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 125. Mylan Daptomycin Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Mylan Recent Developments
Table 127. Fresenius Kabi Company Information
Table 128. Fresenius Kabi Description and Major Businesses
Table 129. Fresenius Kabi Daptomycin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 130. Fresenius Kabi Daptomycin Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Fresenius Kabi Recent Developments
Table 132. Sagent Pharmaceuticals Company Information
Table 133. Sagent Pharmaceuticals Description and Major Businesses
Table 134. Sagent Pharmaceuticals Daptomycin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 135. Sagent Pharmaceuticals Daptomycin Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Sagent Pharmaceuticals Recent Developments
Table 137. Xellia Company Information
Table 138. Xellia Description and Major Businesses
Table 139. Xellia Daptomycin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 140. Xellia Daptomycin Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Xellia Recent Developments
Table 142. Hisun Company Information
Table 143. Hisun Description and Major Businesses
Table 144. Hisun Daptomycin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 145. Hisun Daptomycin Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Hisun Recent Developments
Table 147. HENGRUI PHARMA Company Information
Table 148. HENGRUI PHARMA Description and Major Businesses
Table 149. HENGRUI PHARMA Daptomycin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 150. HENGRUI PHARMA Daptomycin Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. HENGRUI PHARMA Recent Developments
Table 152. Huadong Medicine Company Information
Table 153. Huadong Medicine Description and Major Businesses
Table 154. Huadong Medicine Daptomycin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 155. Huadong Medicine Daptomycin Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Huadong Medicine Recent Developments
Table 157. Key Raw Materials Lists
Table 158. Raw Materials Key Suppliers Lists
Table 159. Daptomycin Distributors List
Table 160. Daptomycin Customers List
Table 161. Daptomycin Market Trends
Table 162. Daptomycin Market Drivers
Table 163. Daptomycin Market Challenges
Table 164. Daptomycin Market Restraints
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of Figures
Figure 1. Daptomycin Product Picture
Figure 2. Global Daptomycin Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Daptomycin Market Share by Type in 2022 & 2029
Figure 4. 350 mg Lyophilized Powder Product Picture
Figure 5. 500 mg Lyophilized Powder Product Picture
Figure 6. Global Daptomycin Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Daptomycin Market Share by Application in 2022 & 2029
Figure 8. Adult
Figure 9. Pediatric Patients (1 to 17 years of age)
Figure 10. Daptomycin Report Years Considered
Figure 11. Global Daptomycin Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Daptomycin Revenue 2018-2029 (US$ Million)
Figure 13. Global Daptomycin Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 14. Global Daptomycin Revenue Market Share by Region (2018-2029)
Figure 15. Global Daptomycin Sales 2018-2029 ((K Units)
Figure 16. Global Daptomycin Sales Market Share by Region (2018-2029)
Figure 17. US & Canada Daptomycin Sales YoY (2018-2029) & (K Units)
Figure 18. US & Canada Daptomycin Revenue YoY (2018-2029) & (US$ Million)
Figure 19. Europe Daptomycin Sales YoY (2018-2029) & (K Units)
Figure 20. Europe Daptomycin Revenue YoY (2018-2029) & (US$ Million)
Figure 21. China Daptomycin Sales YoY (2018-2029) & (K Units)
Figure 22. China Daptomycin Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Asia (excluding China) Daptomycin Sales YoY (2018-2029) & (K Units)
Figure 24. Asia (excluding China) Daptomycin Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Daptomycin Sales YoY (2018-2029) & (K Units)
Figure 26. Middle East, Africa and Latin America Daptomycin Revenue YoY (2018-2029) & (US$ Million)
Figure 27. The Daptomycin Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 28. The Top 5 and 10 Largest Manufacturers of Daptomycin in the World: Market Share by Daptomycin Revenue in 2022
Figure 29. Global Daptomycin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Global Daptomycin Sales Market Share by Type (2018-2029)
Figure 31. Global Daptomycin Revenue Market Share by Type (2018-2029)
Figure 32. Global Daptomycin Sales Market Share by Application (2018-2029)
Figure 33. Global Daptomycin Revenue Market Share by Application (2018-2029)
Figure 34. US & Canada Daptomycin Sales Market Share by Type (2018-2029)
Figure 35. US & Canada Daptomycin Revenue Market Share by Type (2018-2029)
Figure 36. US & Canada Daptomycin Sales Market Share by Application (2018-2029)
Figure 37. US & Canada Daptomycin Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Daptomycin Revenue Share by Country (2018-2029)
Figure 39. US & Canada Daptomycin Sales Share by Country (2018-2029)
Figure 40. U.S. Daptomycin Revenue (2018-2029) & (US$ Million)
Figure 41. Canada Daptomycin Revenue (2018-2029) & (US$ Million)
Figure 42. Europe Daptomycin Sales Market Share by Type (2018-2029)
Figure 43. Europe Daptomycin Revenue Market Share by Type (2018-2029)
Figure 44. Europe Daptomycin Sales Market Share by Application (2018-2029)
Figure 45. Europe Daptomycin Revenue Market Share by Application (2018-2029)
Figure 46. Europe Daptomycin Revenue Share by Country (2018-2029)
Figure 47. Europe Daptomycin Sales Share by Country (2018-2029)
Figure 48. Germany Daptomycin Revenue (2018-2029) & (US$ Million)
Figure 49. France Daptomycin Revenue (2018-2029) & (US$ Million)
Figure 50. U.K. Daptomycin Revenue (2018-2029) & (US$ Million)
Figure 51. Italy Daptomycin Revenue (2018-2029) & (US$ Million)
Figure 52. Russia Daptomycin Revenue (2018-2029) & (US$ Million)
Figure 53. China Daptomycin Sales Market Share by Type (2018-2029)
Figure 54. China Daptomycin Revenue Market Share by Type (2018-2029)
Figure 55. China Daptomycin Sales Market Share by Application (2018-2029)
Figure 56. China Daptomycin Revenue Market Share by Application (2018-2029)
Figure 57. Asia Daptomycin Sales Market Share by Type (2018-2029)
Figure 58. Asia Daptomycin Revenue Market Share by Type (2018-2029)
Figure 59. Asia Daptomycin Sales Market Share by Application (2018-2029)
Figure 60. Asia Daptomycin Revenue Market Share by Application (2018-2029)
Figure 61. Asia Daptomycin Revenue Share by Region (2018-2029)
Figure 62. Asia Daptomycin Sales Share by Region (2018-2029)
Figure 63. Japan Daptomycin Revenue (2018-2029) & (US$ Million)
Figure 64. South Korea Daptomycin Revenue (2018-2029) & (US$ Million)
Figure 65. China Taiwan Daptomycin Revenue (2018-2029) & (US$ Million)
Figure 66. Southeast Asia Daptomycin Revenue (2018-2029) & (US$ Million)
Figure 67. India Daptomycin Revenue (2018-2029) & (US$ Million)
Figure 68. Middle East, Africa and Latin America Daptomycin Sales Market Share by Type (2018-2029)
Figure 69. Middle East, Africa and Latin America Daptomycin Revenue Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Daptomycin Sales Market Share by Application (2018-2029)
Figure 71. Middle East, Africa and Latin America Daptomycin Revenue Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Daptomycin Revenue Share by Country (2018-2029)
Figure 73. Middle East, Africa and Latin America Daptomycin Sales Share by Country (2018-2029)
Figure 74. Brazil Daptomycin Revenue (2018-2029) & (US$ Million)
Figure 75. Mexico Daptomycin Revenue (2018-2029) & (US$ Million)
Figure 76. Turkey Daptomycin Revenue (2018-2029) & (US$ Million)
Figure 77. Israel Daptomycin Revenue (2018-2029) & (US$ Million)
Figure 78. GCC Countries Daptomycin Revenue (2018-2029) & (US$ Million)
Figure 79. Daptomycin Value Chain
Figure 80. Daptomycin Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries